Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Lyndsey L Anderson"'
Autor:
Lyndsey L Anderson, Dilara A Bahceci, Nicole A Hawkins, Declan Everett-Morgan, Samuel D Banister, Jennifer A Kearney, Jonathon C Arnold
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0280842 (2023)
A purified preparation of cannabidiol (CBD), a cannabis constituent, has been approved for the treatment of intractable childhood epilepsies such as Dravet syndrome. Extensive pharmacological characterization of CBD shows activity at numerous molecul
Externí odkaz:
https://doaj.org/article/bb7a769529cf4d5fb03fb7d3a0df6512
Autor:
Nicole A Hawkins, Nicole J Zachwieja, Alison R Miller, Lyndsey L Anderson, Jennifer A Kearney
Publikováno v:
PLoS Genetics, Vol 12, Iss 10, p e1006398 (2016)
A substantial number of mutations have been identified in voltage-gated sodium channel genes that result in various forms of human epilepsy. SCN1A mutations result in a spectrum of severity ranging from mild febrile seizures to Dravet syndrome, an in
Externí odkaz:
https://doaj.org/article/d719922279e249c58933622411345d98
Autor:
Laura MacNair, Irina Mosesova, Jonathon C. Arnold, Maia G. Etchart, Lyndsey L. Anderson, M Hunter Land, Marcel O. Bonn-Miller
Publikováno v:
Cannabis Cannabinoid Res
INTRODUCTION: Legalization of medicinal cannabis around the world has led to an increase in the use of commercial cannabis-based products in the community. These cannabis-based products are being used in combination with conventional drugs to treat a
Autor:
Lyndsey L. Anderson, Declan Everett‐Morgan, Stela P. Petkova, Jill L. Silverman, Jonathon C. Arnold
Publikováno v:
Epilepsia Open.
Autor:
Thomas Harman, Michael Udoh, Dan L. McElroy, Lyndsey L. Anderson, Richard C. Kevin, Samuel D. Banister, Adam Ametovski, Jack Markham, Chris Bladen, Peter T. Doohan, Quentin Greba, Robert B. Laprairie, Terrance P. Snutch, Iain S. McGregor, John G. Howland, Jonathon C. Arnold
Publikováno v:
Frontiers in Physiology. 14
Background: T-type Ca2+ channels (Cav3) represent emerging therapeutic targets for a range of neurological disorders, including epilepsy and pain. To aid the development and optimisation of new therapeutics, there is a need to identify novel chemical
Autor:
Ivan K. Low, Jia Lin Luo, Iain S. McGregor, Jonathon C. Arnold, Richard C. Kevin, Lyndsey L. Anderson, Melissa J. Benson, Cilla Zhou
Publikováno v:
Cannabis and Cannabinoid Research. 7:46-57
Introduction: The cannabinoid Δ9-tetrahydrocannabinolic acid (Δ9-THCA) has long been suggested in review articles and anecdotal reports to be anticonvulsant; yet, there is scant evidence supporting this notion. The objective of this study was to in
Publikováno v:
Frontiers in Physiology. 14
Introduction: Cannabis contains cannabidiol (CBD), the main non-psychoactive phytocannabinoid, but also many other phytocannabinoids that have therapeutic potential in the treatment of epilepsy. Indeed, the phytocannabinoids cannabigerolic acid (CBGA
Publikováno v:
Journal of Clinical Psychopharmacology. 42:422-424
Autor:
Nicole A. Hawkins, Jonathon C. Arnold, Michael T. Bowen, Jennifer A. Kearney, Mary Chebib, Fan Zhang, Iain S. McGregor, Marika Heblinski, Dilara Bahceci, Lyndsey L. Anderson, Nathan L. Absalom, Melissa J. Benson, Peter T. Doohan
Publikováno v:
British Journal of Pharmacology. 178:4826-4841
Background and purpose Cannabis has been used to treat epilepsy for millennia, with such use validated by regulatory approval of cannabidiol (CBD) for the treatment of Dravet syndrome. Unregulated artisanal cannabis-based products used to treat child
Autor:
Richard C. Kevin, Jonathon C. Arnold, Iain S. McGregor, Peter T. Doohan, Lyndsey L. Anderson, Maximus Berger, G. Paul Amminger, Lachlan D. Oldfield
Publikováno v:
Journal of Clinical Psychopharmacology. 41:525-533
Background Cannabidiol (CBD), a major nonintoxicating constituent of cannabis, exhibits anxiolytic properties in preclinical and human studies and is of interest as a novel intervention for treating anxiety disorders. Existing first-line pharmacother